Wuhan Zhongyuan Huadian Science & Technology Co (300018) Fair Value & Analysis
Industrials · CN · Market cap 6.1B CNY
Fair value as of: Jul 7, 2026
From 26 valuation models · updated 34 days ago
Fair value updated Jul 7, 2026, revised from ¥3.31 to ¥2.97 (−10.3%) since Jun 24, 2026. Share price −9.4% over the past month.
A strong business, but screening 75% overvalued on our models.
What matters now
- A high-quality business (quality 77/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case (¥3.65). The favourable scenario is already priced in.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 7, 2026.
How to read this chart
60‑month range ¥3.70 – ¥16.10 · fair‑value band ¥2.29 – ¥3.65 · the ¥11.94 price screens above the ¥2.97 fair value. Dashed = 300-day average. As of Jul 7, 2026.
Analysis
Wuhan Zhongyuan Huadian Science & Technology Co (300018) currently trades at ¥11.94, while our model-based Fair Value estimate is ¥2.97, implying the stock looks roughly 75.1% overvalued today. The Quality Score stands at 77/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Wuhan Zhongyuan Huadian Science & Technology Co generated revenue of 679M CNY at a net margin of 21.0%. Revenue grew 24.2% year over year. It earns a return on equity of 10.3%. The balance sheet holds a net cash position of 124M CNY. Fundamentals as of Jul 7, 2026
Our scenario range runs from ¥2.29 (bear case) to ¥3.65 (bull case); at ¥11.94, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 27% below its 52-week high and 67% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -75%, 300018 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (¥3.60) versus Dividend Discount (¥0.7400). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 7, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 73 · Market factors (momentum, volatility) 58
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. engages in the smart grid, healthcare, and industrial investment businesses in China.
Full company description
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. engages in the smart grid, healthcare, and industrial investment businesses in China. The company offers power system dynamic recording systems, power system time synchronization and measurement systems, smart grid instruments, substation integrated automation systems, distribution network dispatching and integrated automation systems, energy internet system integration, and intelligent equipment; and fault recording waveform, time synchronization, power grid monitoring, information systems, intelligent inspection, power system relay protection testing and distribution network testing equipment, power data recording and analysis equipment, power time measurement and time scale output equipment, and power system integrated testing equipment. It also provides maintenance, commissioning, and operation services for substations and distribution networks, as well as planning, design, consulting, and operation, and maintenance services for the energy internet. In addition, it offers products and services to medical institutions, health administration departments, and individuals; and produces various categories of biochemical in vitro diagnostic reagents and medical testing equipment. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. was founded in 2001 and is headquartered in Wuhan, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
Wuhan Zhongyuan Huadian Science & Technology Co reported revenue of ¥554M in FY2024 versus ¥406M in FY2020, a compound +8.0%/yr. Reported net income was ¥77.0M in FY2024, compounding +13.9%/yr from FY2020.
300018 screens 75% overvalued. Compare with GE Vernova Inc →
Peer Group
Specialty Industrial Machinery · 809 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Industrial Machinery median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc 1GEV | €887.60 | €186.93 | -79% |
| 1SIE 1SIE | €273.20 | €91.93 | -66% |
| SMNS SMNS | C$31.76 | C$22.68 | -29% |
| Eaton Corporation ETN | $407.28 | $171.92 | -58% |
| Atlas Copco AB ATCOA | kr 195.15 | kr 112.59 | -42% |
| Sandvik AB SAND | kr 384.10 | kr 193.01 | -50% |
| Doosan Enerbility Co 034020 | 76,400 KRW | 7,938 KRW | -90% |
| Vestas Wind Systems A/S VWS | kr 178.10 | kr 124.54 | -30% |
| Zhejiang Sanhua Intelligent Controls Co 002050 | ¥43.20 | ¥22.68 | -48% |
| NARI Technology Co 600406 | ¥22.19 | ¥18.71 | -16% |
Compare Wuhan Zhongyuan Huadian Science & Technology Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Wuhan Zhongyuan Huadian Science & Technology Co (300018) overvalued or undervalued?
What is the fair value of 300018?
What is the quality score of 300018?
What is the revenue of Wuhan Zhongyuan Huadian Science & Technology Co (300018)?
What is the net profit margin of 300018?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Wuhan Zhongyuan Huadian Science & Technology Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.